Woodline Partners LP - TURNING POINT THERAPEUTICS I ownership

Quarter-by-quarter ownership
Woodline Partners LP ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$16,606,000
+646.3%
220,676
+166.3%
0.26%
+611.1%
Q1 2022$2,225,000
-53.7%
82,856
-17.7%
0.04%
-47.8%
Q4 2021$4,801,000
+43.9%
100,644
+100.4%
0.07%
+27.8%
Q3 2021$3,337,000
-9.0%
50,228
+6.9%
0.05%
-20.6%
Q2 2021$3,667,000
-16.1%
47,000
+1.7%
0.07%
-29.9%
Q1 2021$4,370,000
-64.8%
46,200
-76.8%
0.10%
-80.9%
Q4 2019$12,419,000199,3780.51%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders